Clinical Genome Resource, Cancer Genomics Consortium, and Variant Interpretation for Cancer Consortium 2022 Variant Interpretation Guidelines

**Semantic type:** Intellectual Product

**Definition:** Guidelines released in 2022 by stakeholders in the Clinical Genome Resource (ClinGen) Somatic Cancer Clinical Domain Working Group, the ClinGen Germline/Somatic Variant Subcommittee, the Cancer Genomics Consortium (CGC), and the Variant Interpretation and reporting for Cancer Consortium (VICC) for the interpretation and reporting of variant pathogenicity in clinical genomic and genetic testing.

**Synonyms:** - 2022 ClinGen/CGC/VICC Classification - ClinGen/CGC/VICC 2022 - ClinGen/CGC/VICC 2022 Guidelines - ClinGen/CGC/VICC 2022 Variant Interpretation Guidelines